久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Oxford BioDynamics signs deal to develop ASD biomarkers pharmatimes
    November 14, 2018
    Oxford BioDynamics (OBDs) has signed a collaboration agreement with Italian research and biomedical institute Casa Sollievo della Sofferenza to develop a diagnostic biomarker assay for Autism Spectrum Disorder (ASD).
PharmaSources Customer Service